Karen Vanhoorelbeke

Full professor
Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium
Kortrijk, West-Vlaanderen, Belgium

Presentation(s):

• OC 15.5 - The conformational opening of ADAMTS13 does not necessarily indicate preactivation of its metalloprotease domain.

  Sunday, June 23, 2024
  10:30 – 10:45 ICT

• PB0274 - Re-establishing von Willebrand Factor production in endothelial cells derived from von Willebrand Disease type 3 canine models through CRISPR-Cas9 mediated gene editing

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0855 - TGD001, a VWF-targeted thrombolytic, is safe and effective in animal models for the treatment of thrombotic thrombocytopenic purpura

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 58.5 - N-glycan mediated shielding of the CUB domains of ADAMTS13 prevents binding of C-terminal antibodies in patients with immune-mediated TTP

  Tuesday, June 25, 2024
  10:30 – 10:45 ICT

• OC 59.4 - A Microfluidic Approach in TTP Highlights the Need to Normalise ADAMTS13 Activity Levels in Clinical Remission in iTTP and the Effect of Different Treatments on Disease Activity in cTTP

  Tuesday, June 25, 2024
  10:15 – 10:30 ICT